Early-onset Parkinson's disease (EOPD) is distinct from the classic late-onset PD (LOPD) because of its slower disease progression. the aim of this study was to compare dopamine neuronal loss in EOPD with that of LOPD with the same disease duration, through dopamine transporter (DAT) estimation. Fourteen patients, seven EOPD (< 50 years) and seven LOPD, matched for disease duration were scanned with [Tc-99m]-TRODAT-1-SPECT (INER-Taiwan), and were assessed with standard PD scales. EOPD patients had 34% lower striatal DAT binding potential (BP) compared with that of LOPD patients (BP = 0.29 +/- 0.12, BP = 0.44 +/- 0.12, P < 0.02) with similar PD severity. These results suggest that EOPD patients have greater dopamine density loss than LOPD pa...
Objective: To explore the association between striatal dopaminergic deficits and cognitive impairmen...
Approximately 10% of patients with a presumed diagnosis of Parkinson's disease (PD) remain misdiagno...
Parkinson's disease (PD) is characterized by a progressive loss of nigrostriatal dopaminergic neuron...
Background: Neuropathological studies, based on small samples, suggest that symptoms of Parkinson'...
Background: Although the decrease in striatal dopamine transporter (DAT) density has been described ...
INTRODUCTION: In idiopathic Parkinson's disease (PD), two different clinical phenotypes are usually...
Source of support: This study was funded by Sao Paulo Research Foundation (FAPESP) Background: Altho...
The mechanism underlying non-motor symptoms in Parkinson's disease has not yet been elucidated. In t...
Previous molecular imaging studies comparing dopamine function in vivo between early-onset PD and la...
Objectives: To evaluate patients with clinically established psychogenic parkinsonism (PsyP) using s...
OBJECTIVES: Patients with Parkinson's disease (PD) have higher-order discriminative sensory dysfunct...
Background: White matter hyperintensities, prevalent in patients with Parkinson's disease (PD), sign...
Objective: To investigate whether the patterns of striatal dopamine depletion on dopamine transporte...
The variability in clinical features and the masking effects of drug therapy in Parkinson's disease ...
Dopamine transporter (DAT) single-photon emission tomography (SPECT) with (123)Ioflupane is a widely...
Objective: To explore the association between striatal dopaminergic deficits and cognitive impairmen...
Approximately 10% of patients with a presumed diagnosis of Parkinson's disease (PD) remain misdiagno...
Parkinson's disease (PD) is characterized by a progressive loss of nigrostriatal dopaminergic neuron...
Background: Neuropathological studies, based on small samples, suggest that symptoms of Parkinson'...
Background: Although the decrease in striatal dopamine transporter (DAT) density has been described ...
INTRODUCTION: In idiopathic Parkinson's disease (PD), two different clinical phenotypes are usually...
Source of support: This study was funded by Sao Paulo Research Foundation (FAPESP) Background: Altho...
The mechanism underlying non-motor symptoms in Parkinson's disease has not yet been elucidated. In t...
Previous molecular imaging studies comparing dopamine function in vivo between early-onset PD and la...
Objectives: To evaluate patients with clinically established psychogenic parkinsonism (PsyP) using s...
OBJECTIVES: Patients with Parkinson's disease (PD) have higher-order discriminative sensory dysfunct...
Background: White matter hyperintensities, prevalent in patients with Parkinson's disease (PD), sign...
Objective: To investigate whether the patterns of striatal dopamine depletion on dopamine transporte...
The variability in clinical features and the masking effects of drug therapy in Parkinson's disease ...
Dopamine transporter (DAT) single-photon emission tomography (SPECT) with (123)Ioflupane is a widely...
Objective: To explore the association between striatal dopaminergic deficits and cognitive impairmen...
Approximately 10% of patients with a presumed diagnosis of Parkinson's disease (PD) remain misdiagno...
Parkinson's disease (PD) is characterized by a progressive loss of nigrostriatal dopaminergic neuron...